The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle
to successful antiretroviral therapy (ART) in the low-and middle-income countries (LMICs) …

Background COVID-19 has been the most important public health concern worldwide since
2020. Several vaccines are now available to help in controlling COVID-19 associated …

The extent of SARS-CoV-2 circulation in many African countries remains unclear,
underlining the need for antibody sero-surveys to assess the cumulative attack rate. Here …

HIV drug resistance (HIVDR) is a major challenge to the effectiveness of antiretroviral
therapy. Global efforts in addressing HIVDR require clear, transparent, and replicable …

Background The mother-to-child transmission of HIV-1 (MTCT) remains on the major route of
HIV-transmission among pediatric populations in Africa. Though a prevention of MTCT …

Background Management and control of the COVID-19 pandemic caused by the severe
acute respiratory syndrome coronavirus SARS-CoV-2 is critically dependent on quick and …

Background After the launching of the «Test & Treat» strategy and the wider accessibility to
viral load (VL), evaluating virological success (VS) would help in meeting the UNAIDS …

While the SARS-CoV-2 dynamic has been described globally, there is a lack of data from
Sub-Saharan Africa. We herein report the dynamics of SARS-CoV-2 lineages from March …

Introduction: The number of HIV‐infected children and adolescents requiring second‐line
antiretroviral treatment (ART) is increasing in low‐and middle‐income countries (LMIC) …

Introduction Limited studies have reported the outcomes of lifelong antiretroviral therapy
(ART) amongst adolescents living with HIV (ALWHIV) in resource-limited settings (RLS) …